Analysing and interpreting competing risk data

Statistics in Medicine

Volumn 26, Issue 6, 2007, Pages 1360-1367

  Pintilie, Melania ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cause specific hazard; Competing risk; Hazard of the subdistribution; Interpretation; Modelling

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BIRTH; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; ELECTRIC POWER PLANT; FINANCIAL MANAGEMENT; HODGKIN DISEASE; HOSPITAL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; NASOPHARYNX CANCER; NURSE; PHYSICIAN; PROGNOSIS; RISK ASSESSMENT; SCHOOL; STATISTICAL MODEL;

CAUSALITY; DATA INTERPRETATION, STATISTICAL; HUMANS; ONTARIO; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT;

EID: 33847761073     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2655     Document Type: Article

References (7)

1. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine 1999; 18:695-706.
2. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics 1988; 16:1141-1154.
3. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association 1999; 94:496-509.
4. Latouche A, Porcher R, Chevret S. Sample size formula for proportional hazards modelling of competing risks. Statistics in Medicine 2004; 23:3263-3274.
5. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: Hoboken, New Jersey, 2002.
6. Shi W, Pataki I, MacMillan C, Pintilie M, Payne D, O'Sullivan B, Cummings BJ, Warde P, Liu FF. Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer 2002; 94:1997-2006.
7. Makitie AA, MacMillan C, Ho J, Shi W, Lee A, O'Sullivan B, Payne D, Pintilie M, Cummings B, Waldron J, Warde P, Irish J, Brown D, Gilbert R, Gullane P, Liu FF, Kamel-Reid S. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clinical Cancer Research 2003; 9:2177-2184.